List of works - Ali Rihani

17q24.2 microdeletions: a new syndromal entity with intellectual disability, truncal obesity, mood swings and hallucinations

scientific article published on 14 December 2011

An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours.

scientific article published on 12 April 2010

Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.

scientific article

CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients

scientific article

Cost-effective and robust genotyping using double-mismatch allele-specific quantitative PCR

scientific article published in Scientific Reports

Effective Alu repeat based RT-Qpcr normalization in cancer cell perturbation experiments

scientific article

Escape from p53-mediated tumor surveillance in neuroblastoma: switching off the p14(ARF)-MDM2-p53 axis.

scientific article published on 25 September 2009

Expressed repetitive elements are broadly applicable reference targets for normalization of reverse transcription-qPCR data in mice.

scientific article

Functional analysis of the p53 pathway in neuroblastoma cells using the small-molecule MDM2 antagonist nutlin-3.

scientific article published on April 2011

Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma

scientific article

Inhibition of CDK4/6 as a novel therapeutic option for neuroblastoma.

scientific article published on 30 July 2015

Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma.

scientific article published on 4 January 2014

Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer

scientific article

The need for transparency and good practices in the qPCR literature.

scientific article published in November 2013

Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer Compounds

scientific article published on 04 February 2020

miRBase Tracker: keeping track of microRNA annotation changes.

scientific article

List of works by Ali Rihani

17q24.2 microdeletions: a new syndromal entity with intellectual disability, truncal obesity, mood swings and hallucinations

An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours.

Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.

CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients

Cost-effective and robust genotyping using double-mismatch allele-specific quantitative PCR

Effective Alu repeat based RT-Qpcr normalization in cancer cell perturbation experiments

Escape from p53-mediated tumor surveillance in neuroblastoma: switching off the p14(ARF)-MDM2-p53 axis.

Expressed repetitive elements are broadly applicable reference targets for normalization of reverse transcription-qPCR data in mice.

Functional analysis of the p53 pathway in neuroblastoma cells using the small-molecule MDM2 antagonist nutlin-3.

Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma

Inhibition of CDK4/6 as a novel therapeutic option for neuroblastoma.

Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma.

Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer

The need for transparency and good practices in the qPCR literature.

Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer Compounds

miRBase Tracker: keeping track of microRNA annotation changes.